SOUTHLAKE, Texas – October 5, 2022 – OncoNano Medicine, Inc. today announced it will be…

– Former Assistant Secretary of Health and Admiral in the U.S. Public Health Service to…

Update on pH-sensitive fluorescent nanoprobe from late-breaking oral presentation at The World Molecular Imaging Congress…

OncoNano Medicine Announces Positive Preclinical Data for ONM-501 at AACR Virtual Conference on Tumor Immunology…

OncoNano Medicine to Present at The American Association for Cancer Research Virtual Conference on Tumor…

Financing round led by Advantech healthcare investment team Funds will support Phase 3 program for…

SOUTHLAKE, Texas – July 19, 2021 – OncoNano Medicine, Inc. today announced a presentation at the…

OncoNano Medicine Announces Martin Driscoll as Chief Executive Officer Mr. Driscoll’s deep experience in the…